MARKET WRAP: Sensex ends 207 pts up led by RIL, Sun Pharma; Rupee hits 70/$
Among sectoral indices, the Nifty Pharma index ended over 3 per cent higher led by rise in the shares of Sun Pharmaceutical Industries and Lupin.
 "markets, stocks, sensex, nifty, bse, nse")
Photo: Shutterstock
The benchmark indices ended higher on Tuesday, taking cues from their global peers and helped by pharmaceutical, information technology and financial stocks.
The S&P BSE Sensex ended at 37,852, up 207 points while the broader Nifty50 index settled at 11,435, up 79 points.
In key stocks, the market heavyweight Reliance Industries (RIL) rose 2 per cent to Rs 1,210.95 levels on the BSE. Sun Pharmaceutical Industries too surged around 7 per cent to end at Rs 601.65.
The S&P BSE Sensex ended at 37,852, up 207 points while the broader Nifty50 index settled at 11,435, up 79 points.
In key stocks, the market heavyweight Reliance Industries (RIL) rose 2 per cent to Rs 1,210.95 levels on the BSE. Sun Pharmaceutical Industries too surged around 7 per cent to end at Rs 601.65.
Among sectoral indices, the Nifty Pharma index ended over 3 per cent higher led by rise in the shares of Sun Pharmaceutical Industries while Nifty IT index ended nearly 1 per cent up led by MindTree. The Nifty Realty index ended nearly 2 per cent led by DLF and Housing Development and Infrastructure.
Rupee
The rupee breached 70 per dollar, hitting an all-time low on Tuesday after diving by Rs 1.09 to close at an all-time low of Rs 69.92 against the US dollar on Monday, bowing to a global rout in currencies on fears of an economic crisis in Turkey. It was the biggest single-day fall in almost five years.
Global Markets
World share markets regained their footing on Tuesday as the threat from the collapse of the Turkish lira ebbed and reassuring German data offset signs of slowing growth in China.
Japan’s Nikkei held onto its early 1.1 per cent gain, while Australian stocks added 0.8 per cent. The Shanghai blue chip index was off 0.6 per cent and weighing on MSCI’s broadest index of Asia-Pacific shares outside Japan which eased 0.2 per cent.
Japan’s Nikkei held onto its early 1.1 per cent gain, while Australian stocks added 0.8 per cent. The Shanghai blue chip index was off 0.6 per cent and weighing on MSCI’s broadest index of Asia-Pacific shares outside Japan which eased 0.2 per cent.
(with wire inputs)
3:49 PM
Nifty Pharma index ends 3.21% higher. Top gainers:
| COMPANY | LATEST | PREV CLOSE | GAIN() | GAIN(%) |
|---|---|---|---|---|
| SUN PHARMA.INDS. | 601.80 | 563.90 | 37.90 | 6.72 |
| BIOCON | 589.40 | 571.70 | 17.70 | 3.10 |
| DIVI'S LAB. | 1154.55 | 1120.20 | 34.35 | 3.07 |
| LUPIN | 836.75 | 811.95 | 24.80 | 3.05 |
| CIPLA | 642.75 | 628.30 | 14.45 | 2.30 |
3:37 PM
Nifty sectoral gainers and losers
3:35 PM
BSE Sensex: Sun Pharma, YES Bank, RIL among top gainers of the day
3:33 PM
Market at close
The S&P BSE Sensex ended at 37,852, up 207 points while the broader Nifty50 index settled at 11,435, up 79 points.
The S&P BSE Sensex ended at 37,852, up 207 points while the broader Nifty50 index settled at 11,435, up 79 points.
3:12 PM
External factors, selective intervention by RBI led to rupee's fall: Garg
The government on Tuesday blamed "external factors" for the rupee's fall to an all-time low against the US dollar and said there is nothing to worry. Economic Affairs Secretary Subhash Chander Garg said external factors may ease going forward. READ MORE
3:02 PM
Sun Pharma rallies 7% as Q1 profit beats Street estimates
Shares of Sun Pharmaceutical Industries have rallied 7% to Rs 600 per share on the BSE after the pharmaceutical company reported a better-than-expected consolidated net profit at Rs 9.83 billion in June quarter (Q1FY19). The company had posted a loss of Rs 4.25 billion in the same quarter year ago. READ MORE
2:44 PM
MCX to launch rubber futures on Aug 16
Leading commodity bourse MCX today announced launching of the rubber futures from August 16 to provide hedging to the entire value chain in the rubber industry. The MCX said it will offer four futures contracts in rubber with each ending September, October, November and December, respectively, an official statement said. READ MORE
2:30 PM
Sebi's consent route to ease pending case load yields success in FY18
Markets regulator Securities and Exchange Board of India (Sebi) settled double the number of cases through the so-called consent mechanism in 2017-18, compared to the previous fiscal. According to data, Sebi resolved 200 cases through the consent route last fiscal as against 103 in 2016-17.
The amount earned by Sebi as settlement fees also saw a more than two-fold increase to Rs 300 million in FY18, compared to Rs 135 million in FY17. READ MORE
2:15 PM
STOCK ALERT Cadila Healthcare nears 52-week low post June quarter results
Shares of Cadila Healthcare have slipped 5% to Rs 336 per share, extending their 6% decline on Monday on the BSE, after the company reported a lower-than-expected 30% year on year (YoY) growth in net sales at Rs 28.94 billion in the June quarter (Q1FY19) due to lower US sales.
The company’s net profit grew by 233% YoY to Rs 4.60 billion in Q1FY19 due to other income of Rs 1.01 billion. READ MORE
2:00 PM
Market Check
> More on NSE Indices
| INDEX | LATEST | PREVIOUS | CHANGE | CHANGE(%) |
|---|---|---|---|---|
| NIFTY 50 | 11439.80 | 11355.75 | 84.05 | 0.74 |
| NIFTY 500 | 9718.75 | 9656.50 | 62.25 | 0.64 |
| NIFTY MIDCAP 100 | 19114.50 | 19012.40 | 102.10 | 0.54 |
| NIFTY SMALL 100 | 7473.65 | 7463.65 | 10.00 | 0.13 |
| INDIA VIX | 13.23 | 13.40 | -0.17 | -1.27 |
Topics :
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 14 2018 | 8:15 AM IST